CID 100299

Tocladesine

Structural Information

Molecular Formula
C10H11ClN5O6P
SMILES
C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3Cl)N)O)OP(=O)(O1)O
InChI
InChI=1S/C10H11ClN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1
InChIKey
CLLFEJLEDNXZNR-UUOKFMHZSA-N
Compound name
(4aR,6R,7R,7aS)-6-(6-amino-8-chloropurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

277
References

1913
Patents

363.01355 Da
Monoisotopic Mass

-1.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 364.02083 173.9
[M+Na]+ 386.00277 184.7
[M+NH4]+ 381.04737 179.3
[M+K]+ 401.97671 185.6
[M-H]- 362.00627 176.7
[M+Na-2H]- 383.98822 174.0
[M]+ 363.01300 176.1
[M]- 363.01410 176.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe